Unlocking the Potential of HER2-Targeted Treatments
EU Research · 2025-03 · Spring 2025 (41) · 12-13
DOI: 10.56181//imii5025 ↗Kurz gefasst
Fachartikel in der Zeitschrift EU Research, 2025-03. Verfasst von Morten Mau Sorensen und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
We spoke to Chief Oncologist Dr. Morten Mau Sorensen and Dr. Kristian Egebjerg from Copenhagen University Hospital – Rigshospitalet in Denmark, whose research focuses on expanding HER2-targeted therapies to esophageal squamous cell carcinoma and improving diagnostic methods to identify HER2-positive patients across various cancer types.
Zitieren
APA
Sorensen, M. M., & Egebjerg, K. (2025). Unlocking the Potential of HER2-Targeted Treatments. EU Research, Spring 2025(41), 12-13. https://doi.org/10.56181//imii5025
Vancouver
Sorensen MM, Egebjerg K. Unlocking the Potential of HER2-Targeted Treatments. EU Research. 2025;Spring 2025(41):12-13. doi:10.56181//imii5025
BibTeX
@article{Sorensen2025,
author = {Sorensen, Morten Mau and Egebjerg, Kristian},
title = {Unlocking the Potential of HER2-Targeted Treatments},
journal = {EU Research},
year = {2025},
volume = {Spring 2025},
number = {41},
pages = {12--13},
doi = {10.56181//imii5025}
}
EUVIMED